サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1420983

甲状腺疾患治療市場：世界の業界分析、規模、シェア、成長、動向、予測、2023年～2031年

Thyroid Gland Disorders Treatment Market (Disorders: Hypothyroidism and Hyperthyroidism) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 173 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.36円
甲状腺疾患治療市場：世界の業界分析、規模、シェア、成長、動向、予測、2023年～2031年
出版日: 2023年12月01日
発行: Transparency Market Research
ページ情報: 英文 173 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

甲状腺疾患治療市場- レポートの範囲

世界の甲状腺疾患治療市場に関するTMRのレポートは、過去と現在の成長動向、および2023年から2031年の予測期間中に市場の指標の貴重な洞察を得る機会を研究しています。このレポートは、世界の甲状腺疾患治療市場の収益を提供し、2023年を基準年、2031年を予測年として考慮し、2017年から2031年の期間を対象としています。このレポートは、2023年から2031年までの世界の甲状腺疾患治療市場の複合年間成長率（CAGR %）も提供します。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、甲状腺疾患治療市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

市場スナップショット
2023年の市場価値 22億米ドル
2031年の市場価値 33億米ドル
CAGR 4.7%

このレポートは、世界の甲状腺疾患治療市場の競合情勢を詳しく調査しています。世界の甲状腺疾患治療市場で活動する主要企業が特定され、これらのそれぞれがさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界の甲状腺疾患治療市場のプレーヤーの属性です。

目次

第1章 エグゼクティブサマリー

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • 市場セグメンテーション
  • 概要
  • 市場力学
  • 世界市場の分析と予測、2023～2031年

第5章 重要な洞察

  • パイプライン分析
  • 甲状腺疾患検査の種類一覧
  • 主要国の世界の病気の有病率と発症率
  • COVID-19のパンデミックが業界に与える影響

第6章 市場分析と予測：疾患別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：疾患別、2023-2031
    • 甲状腺機能低下症
      • レボチロキシン
      • リオチロニン
    • 甲状腺機能亢進症
      • イミダゾール
      • プロパシル
  • 市場の魅力度：疾患別

第7章 世界市場の分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別、2023-2031
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力度：地域別

第8章 北米市場の分析と予測

第9章 欧州市場の分析と予測

第10章 アジア太平洋市場の分析と予測

第11章 ラテンアメリカ市場の分析と予測

第12章 中東およびアフリカ市場の分析と予測

第13章 競合情勢

  • 市場プレーヤー-競合マトリックス（企業の階層および規模別）
  • 市場シェア分析：企業別（2022年）
  • 企業プロファイル
    • Merck KGaA
    • Pfizer, Inc.
    • Takeda Pharmaceutical Company Ltd.
    • Allergan
    • Sanofi SA
    • AbbVie Inc.
    • Lannet Company, Inc.
    • Aspen
図表

List of Tables

  • Table 1: Global Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorder, 2023-2031
  • Table 2: Global Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Region, 2023-2031
  • Table 3: North America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Country, 2023-2031
  • Table 4: North America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorder, 2023-2031
  • Table 5: Europe Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 6: Europe Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorder, 2023-2031
  • Table 7: Asia Pacific Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 8: Asia Pacific Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorder, 2023-2031
  • Table 9: Latin America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 10: Latin America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorder, 2023-2031
  • Table 11: Middle East & Africa Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2032-2031
  • Table 12: Middle East & Africa Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorder, 2023-2031

List of Figures

  • Figure 1: Global Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 2: Global Thyroid Gland Disorders Treatment Market Value Share, by Disorder, 2022
  • Figure 3: Global Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorder, 2022 and 2031
  • Figure 4: Global Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorder, 2023-2031
  • Figure 5: Global Thyroid Gland Disorders Treatment Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 6: Global Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 7: North America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 8: North America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 9: North America Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 10: North America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorder, 2022 and 2031
  • Figure 11: North America Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorder, 2023-2031
  • Figure 12: Europe Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 13: Europe Thyroid Gland Disorders Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 14: Europe Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 15: Europe Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorder, 2022 and 2031
  • Figure 16: Europe America Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorder, 2023-2031
  • Figure 17: Asia Pacific Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 18: Asia Pacific Thyroid Gland Disorders Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 19: Asia Pacific Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 20: Asia Pacific Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorder, 2022 and 2031
  • Figure 21: Asia Pacific America Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorder, 2023-2031
  • Figure 22: Latin America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 23: Latin America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 24: Latin America Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 25: Latin America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorder, 2022 and 2031
  • Figure 26: Latin America Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorder, 2023-2031
  • Figure 27: Middle East & Africa Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 28: Middle East & Africa Thyroid Gland Disorders Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 29: Middle East & Africa Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 30: Middle East & Africa America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorder, 2023-2031
  • Figure 31: Middle East & Africa America Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorder, 2023-2031
  • Figure 32: Global Thyroid Gland Disorders Treatment Market Share Analysis, by Company (2022)
目次
Product Code: TMRGL3113

Thyroid Gland Disorders Treatment Market - Scope of Report

TMR's report on the global thyroid gland disorders treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global thyroid gland disorders treatment market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global thyroid gland disorders treatment market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the thyroid gland disorders treatment market.

Market Snapshot
Market Value in 2023US$ 2.2 Bn
Market Value in 2031US$ 3.3 Bn
CAGR4.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global thyroid gland disorders treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global thyroid gland disorders treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global thyroid gland disorders treatment market.

The report delves into the competitive landscape of the global thyroid gland disorders treatment market. Key players operating in the global thyroid gland disorders treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global thyroid gland disorders treatment market profiled in this report.

Key Questions Answered in Global thyroid gland disorders treatment Market Report:

  • What is the sales/revenue generated by thyroid gland disorders treatment across all regions during the forecast period?
  • What are the opportunities in the global thyroid gland disorders treatment market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Thyroid Gland Disorders Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global thyroid gland disorders treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global thyroid gland disorders treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global thyroid gland disorders treatment market.

Table of Contents

1. Executive Summary

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Thyroid Gland Disorders Treatment Market

4. Market Overview

  • 4.1. Market Segmentation
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Thyroid Gland Disorders Treatment Market Analysis and Forecast, 2023-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. List of Types of Thyroid Gland Disorder Tests
  • 5.3. Disorder Prevalence & Incidence Rate Globally With Key Countries
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Thyroid Gland Disorders Treatment Market Analysis and Forecast, by Disorder

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Disorder, 2023-2031
    • 6.3.1. Hypothyroidism
      • 6.3.1.1. Levothyroxine
      • 6.3.1.2. Liothyronine
    • 6.3.2. Hyperthyroidism
      • 6.3.2.1. Imidazole
      • 6.3.2.2. Propacil
  • 6.4. Market Attractiveness, by Disorder

7. Global Thyroid Gland Disorders Treatment Market Analysis and Forecast, by Region

  • 7.1. Key Findings
  • 7.2. Market Value Forecast, by Region, 2023-2031
    • 7.2.1. North America
    • 7.2.2. Europe
    • 7.2.3. Asia Pacific
    • 7.2.4. Latin America
    • 7.2.5. Middle East & Africa
  • 7.3. Market Attractiveness, by Region

8. North America Thyroid Gland Disorders Treatment Market Analysis and Forecast

  • 8.1. Introduction
    • 8.1.1. Key Findings
  • 8.2. Market Value Forecast, by Disorder, 2023-2031
    • 8.2.1. Hypothyroidism
      • 8.2.1.1. Levothyroxine
      • 8.2.1.2. Liothyronine
    • 8.2.2. Hyperthyroidism
      • 8.2.2.1. Imidazole
      • 8.2.2.2. Propacil
  • 8.3. Market Attractiveness, by Disorder
  • 8.4. Market Value Forecast, by Country, 2023-2031
    • 8.4.1. U.S.
    • 8.4.2. Canada
  • 8.5. Market Attractiveness Analysis
    • 8.5.1. By Disorder
    • 8.5.2. By Country

9. Europe Thyroid Gland Disorders Treatment Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast, by Disorder, 2023-2031
    • 9.2.1. Hypothyroidism
      • 9.2.1.1. Levothyroxine
      • 9.2.1.2. Liothyronine
    • 9.2.2. Hyperthyroidism
      • 9.2.2.1. Imidazole
      • 9.2.2.2. Propacil
  • 9.3. Market Attractiveness, by Disorder
  • 9.4. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 9.4.1. Germany
    • 9.4.2. U.K.
    • 9.4.3. France
    • 9.4.4. Italy
    • 9.4.5. Spain
    • 9.4.6. Rest of Europe
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Disorder
    • 9.5.2. By Country/Sub-region

10. Asia Pacific Thyroid Gland Disorders Treatment Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Disorder, 2023-2031
    • 10.2.1. Hypothyroidism
      • 10.2.1.1. Levothyroxine
      • 10.2.1.2. Liothyronine
    • 10.2.2. Hyperthyroidism
      • 10.2.2.1. Imidazole
      • 10.2.2.2. Propacil
  • 10.3. Market Attractiveness, by Disorder
  • 10.4. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 10.4.1. China
    • 10.4.2. Japan
    • 10.4.3. India
    • 10.4.4. Australia & New Zealand
    • 10.4.5. Rest of Asia Pacific
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Disorder
    • 10.5.2. By Country/Sub-region

11. Latin America Thyroid Gland Disorders Treatment Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Disorder, 2023-2031
    • 11.2.1. Hypothyroidism
      • 11.2.1.1. Levothyroxine
      • 11.2.1.2. Liothyronine
    • 11.2.2. Hyperthyroidism
      • 11.2.2.1. Imidazole
      • 11.2.2.2. Propacil
  • 11.3. Market Attractiveness, by Disorder
  • 11.4. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 11.4.1. Brazil
    • 11.4.2. Mexico
    • 11.4.3. Rest of Latin America
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Disorder
    • 11.5.2. By Country/Sub-region

12. Middle East & Africa Thyroid Gland Disorders Treatment Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Disorder, 2023-2031
    • 12.2.1. Hypothyroidism
      • 12.2.1.1. Levothyroxine
      • 12.2.1.2. Liothyronine
    • 12.2.2. Hyperthyroidism
      • 12.2.2.1. Imidazole
      • 12.2.2.2. Propacil
  • 12.3. Market Attractiveness, by Disorder
  • 12.4. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 12.4.1. GCC Countries
    • 12.4.2. South Africa
    • 12.4.3. Rest of Middle East & Africa
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Disorder
    • 12.5.2. By Country/Sub-region

13. Competition Landscape

  • 13.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 13.2. Market Share Analysis, by Company (2022)
  • 13.3. Company Profiles
    • 13.3.1. Merck KGaA
      • 13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.1.2. Disorder Portfolio
      • 13.3.1.3. Financial Overview
      • 13.3.1.4. SWOT Analysis
      • 13.3.1.5. Strategic Overview
    • 13.3.2. Pfizer, Inc.
      • 13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.2.2. Disorder Portfolio
      • 13.3.2.3. Financial Overview
      • 13.3.2.4. SWOT Analysis
      • 13.3.2.5. Strategic Overview
    • 13.3.3. Takeda Pharmaceutical Company Ltd.
      • 13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.3.2. Disorder Portfolio
      • 13.3.3.3. Financial Overview
      • 13.3.3.4. SWOT Analysis
      • 13.3.3.5. Strategic Overview
    • 13.3.4. Allergan
      • 13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.4.2. Disorder Portfolio
      • 13.3.4.3. Financial Overview
      • 13.3.4.4. SWOT Analysis
      • 13.3.4.5. Strategic Overview
    • 13.3.5. Sanofi S.A.
      • 13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.5.2. Disorder Portfolio
      • 13.3.5.3. Financial Overview
      • 13.3.5.4. SWOT Analysis
      • 13.3.5.5. Strategic Overview
    • 13.3.6. AbbVie Inc.
      • 13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.6.2. Disorder Portfolio
      • 13.3.6.3. Financial Overview
      • 13.3.6.4. SWOT Analysis
      • 13.3.6.5. Strategic Overview
    • 13.3.7. Lannet Company, Inc.
      • 13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.7.2. Disorder Portfolio
      • 13.3.7.3. Financial Overview
      • 13.3.7.4. SWOT Analysis
      • 13.3.7.5. Strategic Overview
    • 13.3.8. Aspen
      • 13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.8.2. Disorder Portfolio
      • 13.3.8.3. Financial Overview
      • 13.3.8.4. SWOT Analysis
      • 13.3.8.5. Strategic Overview